ANDA 214035

VKT PHARMA

FDA Drug Application

Application #214035

Application Sponsors

ANDA 214035

VKT PHARMA

Marketing Status

• Prescription: 001
• Prescription: 002

Application Products

001	TABLET, EXTENDED RELEASE;ORAL	500MG	0	RANOLAZINE	RANOLAZINE
002	TABLET, EXTENDED RELEASE;ORAL	1GM	0	RANOLAZINE	RANOLAZINE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2022-01-19

STANDARD

Submissions Property Types

ORIG

1

Null

15

TE Codes

001	Prescription	AB
002	Prescription	AB

CDER Filings

VKT PHARMA

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214035
            [companyName] => VKT PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"RANOLAZINE","activeIngredients":"RANOLAZINE","strength":"500MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"RANOLAZINE","activeIngredients":"RANOLAZINE","strength":"1GM","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/19\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-01-19
        )

)